Finance

Lists
Why is OCEA down 60,00%?
Dive Deeper
OCEA:OTCMKTS
Ocean Biomedical Inc
0,00020 USD
-60,00%
(-0,00030) 1D
15-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCEA...
Open
0,00 USD
High
0,00 USD
Low
0,00 USD
Mkt. cap
32,07 миң
Avg. vol.
50,26 миң
Volume
57,56 миң
52-wk high
0,01 USD
52-wk low
0,00 USD
Beta
2,65
Shares outstanding
232,36 млн
No. of employees
7
Open
0,00 USD
High
0,00 USD
Low
0,00 USD
Mkt. cap
32,07 миң
Avg. vol.
50,26 миң
Volume
57,56 миң
52-wk high
0,01 USD
52-wk low
0,00 USD
Beta
2,65
Shares outstanding
232,36 млн
No. of employees
7
News stories
From web sources and news partners
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc
CEO-
Employees7
Founded2019
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2024-ж. июн.
2024-ж. сен.
2024-ж. дек.
2025-ж. мар.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
18,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
768,00 миң
1,75 млн
940,00 миң
Operating expense
-
768,00 миң
1,75 млн
958,00 миң
Total operating expenses
-
768,00 миң
1,75 млн
958,00 миң
Operating income
-
-768,00 миң
-1,75 млн
-958,00 миң
Other non operating income
-
-3,82 млн
2,47 млн
-6,94 млн
EBT including unusual items
-
-5,53 млн
283,00 миң
-8,24 млн
EBT excluding unusual items
-
-5,53 млн
283,00 миң
-8,24 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-5,53 млн
283,00 миң
-8,24 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-461,00 миң
-433,00 миң
-343,00 миң
Net interest expenses
-
-461,00 миң
-433,00 миң
-343,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору